Several other studies have established prognostic models for HCC involving NEIL3 (Wang et al., 2022a; Hu et al., 2022; Ding et al., 2022; Wu et al., 2022; Wu et al., 2021; Wang et al., 2021a; Lu et al., 2023). This evidence concerns the gene NEIL3 and hepatocellular carcinoma.